Back to search
FDAFDA · Food and drugs·Recall number Z-0884-2022

Alinity m HBV AMP Kit (US and CE)

Published April 13, 2022 · Recall initiated: March 4, 2022

Summary

FDA records medical device Class II recall Z-0884-2022, published April 13, 2022 and initiated March 4, 2022. Recalling firm: Abbott Molecular, Inc.; Status: Ongoing; Reported quantity: 4966 kits, updated 101/17/2023; Lot: List Numbers: 1) 08N47-095 (US); Lots: 519756, 523799, and 524361, Updated to add: 381583, 529391, 529687, 530273, 531598; 2) 08N47-090 (CE); Lots: 519755, 520957, 522137, 523798, and 524059, Updated to add: 380963, 380979, 381021, 529378, 529686, 530272, 531189, 531596. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a potential for misquantitation high results for negative samples.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Abbott Molecular, Inc.
Distributor
US consignees - AZ, CA, IL, IN, MA, MI, MO, NH, NJ, NY, OH, SD, TX, and VA OUS consignees - Australia, Austria, Belgium, Brazil, Canada, Columbia, Czech Republic, El Salvador, Estonia, France, Germany, Israel, Italy, Japan, Latvia, Malaysia, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, and Vietnam
Lot
List Numbers: 1) 08N47-095 (US); Lots: 519756, 523799, and 524361, Updated to add: 381583, 529391, 529687, 530273, 531598; 2) 08N47-090 (CE); Lots: 519755, 520957, 522137, 523798, and 524059, Updated to add: 380963, 380979, 381021, 529378, 529686, 530272, 531189, 531596
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Alinity m HBV AMP Kit (US and CE) recalled?

Yes. FDA published recall Z-0884-2022 on April 13, 2022. Reported hazard: There is a potential for misquantitation high results for negative samples.

What should I do if I have this product?

Voluntary: Firm initiated · Letter